A new congressional bill would give patients with life-threatening diseases access to customized gene therapies and medicines.
The Right to Try for Individualized Treatments Act, whose sponsors include U.S. House members from Arizona and Tennessee, would allow patients a pathway to access individualized investigational treatments when no other approved options are available. The bill defines “individualized investigational treatments” as “a drug or biological product for the patient based on an analysis of the patient’s unique genomic profile.” It would allow for medicines and gene therapies, both tailored specifically for the patient.
Treatment must be administered by an eligible healthcare facility “operating under federal assurance for protection of human subjects,” according to the bill.
Doctors or healthcare facilities are not required to offer these treatments, the bill noted.
Read Full Article Here
